Structural Heart Interventions During COVID-19
Department
Internal Medicine
Document Type
Article
Publication Title
Current problems in cardiology
Abstract
The spread of Coronavirus Disease 2019 (COVID-19) pandemic across the globe and the United States presented unprecedented challenges with dawn of new policies to reserve resources and protect the public. One of the major policies adopted by hospitals across the nations were postponement of non-emergent procedures such as transaortic valve replacement (TAVR), left atrial appendage closure device (LAAC), MitraClip and CardioMEMS. Guidelines were based mainly on the avoidable clinical outcomes occurring during COVID-19 era. As our understanding of the SARS-CoV-2 evolved, advanced cardiac procedures may safely continue through careful advanced coordination. We aim to highlight the new guidelines published by different major cardiovascular societies, and discuss solutions to safely perform procedures to improve outcomes in a patient population with high acuity of illness during the COVID-19 pandemic era.
First Page
100934
DOI
10.1016/j.cpcardiol.2021.100934
Publication Date
8-14-2021
Recommended Citation
Obi, K., Baldawi, H., Shamaki, G., Amoran, O., Jenkins, C., Gillies, C., Penfold, D., Dengle, S., Alocozy, L., Falloon, A., & Bob-Manuel, T. (2021). Structural Heart Interventions During COVID-19. Current problems in cardiology, 100934. https://doi.org/10.1016/j.cpcardiol.2021.100934